JP2019510082A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019510082A5 JP2019510082A5 JP2018566649A JP2018566649A JP2019510082A5 JP 2019510082 A5 JP2019510082 A5 JP 2019510082A5 JP 2018566649 A JP2018566649 A JP 2018566649A JP 2018566649 A JP2018566649 A JP 2018566649A JP 2019510082 A5 JP2019510082 A5 JP 2019510082A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- represent
- optionally substituted
- halo
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C*N*(*)[C@@](c1ccccc1)O Chemical compound C*N*(*)[C@@](c1ccccc1)O 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1603886.1 | 2016-03-07 | ||
| GBGB1603886.1A GB201603886D0 (en) | 2016-03-07 | 2016-03-07 | Compounds for the treatment of type 2 diabetes |
| GBGB1701928.2A GB201701928D0 (en) | 2017-02-06 | 2017-02-06 | Compounds for the treatment of hyperglycaemia |
| GB1701928.2 | 2017-02-06 | ||
| PCT/GB2017/050605 WO2017153737A1 (en) | 2016-03-07 | 2017-03-07 | Compounds for the treatment of hyperglycaemia |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019510082A JP2019510082A (ja) | 2019-04-11 |
| JP2019510082A5 true JP2019510082A5 (enExample) | 2020-04-02 |
| JP7046842B2 JP7046842B2 (ja) | 2022-04-04 |
Family
ID=58489714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018566649A Expired - Fee Related JP7046842B2 (ja) | 2016-03-07 | 2017-03-07 | 高血糖症の治療のための化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20190119196A1 (enExample) |
| EP (1) | EP3426239A1 (enExample) |
| JP (1) | JP7046842B2 (enExample) |
| KR (1) | KR20180117696A (enExample) |
| WO (1) | WO2017153737A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014108449A1 (en) | 2013-01-08 | 2014-07-17 | Atrogi Ab | A screening method, a kit, a method of treatment and a compound for use in a method of treatment |
| GB201714736D0 (en) * | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714740D0 (en) * | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714745D0 (en) * | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201903832D0 (en) | 2019-03-20 | 2019-05-01 | Atrogi Ab | New compounds and methods |
| GB202205895D0 (en) | 2022-04-22 | 2022-06-08 | Atrogi Ab | New medical uses |
| CN120583945A (zh) | 2023-01-20 | 2025-09-02 | 阿托基公司 | 用于治疗或预防肌肉消耗的β2-肾上腺素能受体激动剂 |
| GB202302225D0 (en) | 2023-02-16 | 2023-04-05 | Atrogi Ab | New medical uses |
| GB202303229D0 (en) | 2023-03-06 | 2023-04-19 | Atrogi Ab | New medical uses |
| GB202304661D0 (en) * | 2023-03-29 | 2023-05-10 | Atrogi Ab | New compounds and medical uses thereof |
| GB202403169D0 (en) | 2024-03-05 | 2024-04-17 | Atrogi Ab | New medical uses |
| WO2025238248A1 (en) | 2024-05-17 | 2025-11-20 | Atrogi Ab | USE OF β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4814350A (en) * | 1986-09-10 | 1989-03-21 | American Cyanamid Company | Method of treating diabetes with 5-[1-hydroxy-2-(isopropylamino)ethyl]anthranilonitrile |
| US7550133B2 (en) * | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
| CA2538415A1 (en) * | 2003-09-15 | 2005-03-24 | Wilfred Wayne Lautt | Use of antagonists of hepatic sympathetic nerve activity |
| US20050250944A1 (en) | 2004-05-04 | 2005-11-10 | Jian Chen | Synthesis and uses of synephrine derivatives |
| CA2571683A1 (en) | 2004-06-30 | 2006-01-12 | Combinatorx, Incorporated | Methods and reagents for the treatment of metabolic disorders |
| WO2010016939A1 (en) | 2008-08-08 | 2010-02-11 | The Trustees Of Columbia University In The City Of New York | Hypoglycemic dihydropyridones |
| WO2014108449A1 (en) | 2013-01-08 | 2014-07-17 | Atrogi Ab | A screening method, a kit, a method of treatment and a compound for use in a method of treatment |
| US9579288B2 (en) * | 2015-03-03 | 2017-02-28 | Saniona A/S | Tesofensine and beta blocker combination formulations |
-
2017
- 2017-03-07 US US16/082,750 patent/US20190119196A1/en not_active Abandoned
- 2017-03-07 JP JP2018566649A patent/JP7046842B2/ja not_active Expired - Fee Related
- 2017-03-07 EP EP17715967.0A patent/EP3426239A1/en not_active Withdrawn
- 2017-03-07 KR KR1020187028730A patent/KR20180117696A/ko not_active Ceased
- 2017-03-07 WO PCT/GB2017/050605 patent/WO2017153737A1/en not_active Ceased